Home > Journals > Minerva Pediatrics > Past Issues > Minerva Pediatrics 2021 December;73(6) > Minerva Pediatrics 2021 December;73(6):588-605

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  UPDATE IN PEDIATRIC DIABETES AND ENDOCRINOLOGY: PROCEEDING OF THE 7TH WINTER AND SUMMER ISPED SCHOOL FOR PHYSICIANS 

Minerva Pediatrics 2021 December;73(6):588-605

DOI: 10.23736/S2724-5276.21.06544-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Cardiometabolic risk in childhood cancer survivors

Caterina LUONGO 1, Emioli RANDAZZO 2, Lorenzo IUGHETTI 3, Natascia DI IORGI 4, Sandro LOCHE 5, Mohamad MAGHNIE 4, Giuliana VALERIO 6, Maurizio DELVECCHIO 7

1 Department of Woman, Child, General and Specialized Surgery, Luigi Vanvitelli University of Campania, Naples, Italy; 2 Unit of Pediatric Endocrinology and Diabetes, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 3 Unit of Pediatrics, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; 4 Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Genoa, Italy; 5 Unit of Pediatric Endocrinology, Ospedale Pediatrico Microcitemico “A. Cao,” Cagliari, Italy; 6 Department of Movement Sciences and Wellbeing, University of Naples “Parthenope,” Naples, Italy; 7 Unit of Metabolic Disorders and Genetics, Giovanni XXIII Children’s Hospital, Bari, Italy



The Italian Cancer Registry Association has estimated that for the five-year period 2016-2020, in line with the previous five years, approximately 7000 neoplasms have been diagnosed among children and 4000 among adolescents. Leukemias, brain tumors and lymphomas together account for more than two-thirds of all pediatric cancers. Fortunately, the five-years survival rate has progressively improved reaching 80% thanks to the continuing improvement of therapeutic protocols but most of these cancer survivors will have at least one chronic health condition by 40 years of age. Long-term complications concern various organs and systems and have a multifactorial etiopathogenesis. Obesity, diabetes, and metabolic syndrome represent chronic diseases that affect life expectancy. Cardiovascular risk partly linked to therapies and genetic susceptibility and partly linked to the presence of obesity, diabetes and metabolic syndrome predispose childhood cancer survivors to heart failure, coronary artery disease, valvular disease, arrhythmia. Hence the cardio- metabolic risk of childhood cancer survivors can have a significant impact on their lives, families, and on society at-large. Therefore, it is very important to know the risk factors that predispose to the development of cardio-metabolic pathologies in childhood cancer survivors, the possible primary and secondary prevention strategies, the methods of surveillance and the therapeutic approaches.


KEY WORDS: Metabolic syndrome; Cancer survivors; Cardiovascular diseases

top of page